Description

// WHAT_IT_IS

Epithalon (also Epitalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, derived from pineal gland research. Developed by Dr. Vladimir Khavinson and his St. Petersburg lab beginning in the 1980s, this peptide emerged from Soviet-era studies on the pineal extract Epithalamin. What if a peptide could lengthen the protective caps on your DNA that shorten with every cell division?

// MECHANISM

Every time a cell divides, the protective caps on your chromosomes — telomeres — get shorter. Animal research reports Epithalon activates telomerase, the enzyme that can rebuild them. The pathway: Epithalon → Telomerase Activation → Cap Maintenance.

// KEY_RESEARCH_AREAS

• Telomerase activation — upregulation of the enzyme that maintains chromosome caps
• Cellular aging models — 30+ years of mouse, rat, and primate studies
• Pineal gland function — circadian rhythm and melatonin regulation research
• Longevity biomarkers — extensive animal lifespan data (human trials remain limited)

// PROTOCOL

Researchers typically administer Epithalon in 10-day cycles via subcutaneous or intramuscular injection. Common protocols involve 5-10mg daily during active cycles, with cycles repeated 1-2 times per year. Reconstitute with bacteriostatic water before use.

// THE_EVIDENCE

Epithalon has one of the most studied animal lifespan stories in peptide research — and one of the biggest gaps when it comes to modern, controlled human trials replicating those claims. Animal data: extensive (30+ years). Human data: limited. Mostly small Russian elderly studies with no large modern trials.

// DISCLAIMER

Research use only. Not FDA approved. Animal data dominant. This product is intended solely for laboratory and research purposes. Not for human consumption. Educational content only — hype ≠ evidence.